Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
REVTORPYK
product2 mentionslast seen Nov 9, 2026
Gedatolisib, a kinase inhibitor approved for treatment of HR+/HER2- advanced breast cancer.
Relationships 8
- Celcuity Inc.commercializesREVTORPYK98% confidence1 source
- U.S. Food and Drug AdministrationapprovesREVTORPYK97% confidence1 source
- REVTORPYKapplies tohormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer treatment95% confidence1 source
- Celcuity Inc.developsREVTORPYK95% confidence1 source
- REVTORPYKimplementsPI3K/Akt/mTOR pathway inhibition92% confidence1 source
- REVTORPYKdepends onpalbociclib90% confidence1 source
- REVTORPYKdepends onfulvestrant90% confidence1 source
- REVTORPYKapplies tometastatic castration-resistant prostate cancer treatment85% confidence1 source
Relationship
U.S. Food and Drug AdministrationapprovesREVTORPYK
97% confidence1 supporting mentionsfrom Jul 14, 2026
Either name opens that entity’s relationships.
Sources 1